Browsing by Author Ferreri, AJ

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 2 to 4 of 4 < previous 
TitleAuthor(s)Issue DateViews
 
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
Journal:Blood
Xu-Monette, ZYWu, LVisco, CTai, YCTzankov, ALiu, WMMontes-Moreno, SDybkaer, KChiu, AOrazi, AZu, YBhagat, GRichards, KLHsi, EDZhao, XFChoi, WLZhao, Xvan Krieken, JHHuang, QHuh, JAi, WPonzoni, MFerreri, AJZhou, FKahl, BSWinter, JNXu, WLi, JGo, RSLi, YPiris, MAMoller, MBMiranda, RNAbruzzo, LVMedeiros, LJYoung, KH
2012
121
 
Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study
Journal:Haematologica
Visco, CTzankov, AXu-Monette, ZYMiranda, RNTai, YCLi, YLiu, WMd'Amore, ESMontes-Moreno, SDybkaer, KChiu, AOrazi, AZu, YBhagat, GWang, HYDunphy, CHHsi, EDZhao, XFChoi, WLZhao, Xvan Krieken, JHHuang, QAi, WO'Neill, SPonzoni, MFerreri, AJKahl, BSWinter, JNGo, RSDirnhofer, SPiris, MAMoller, MBWu, LMedeiros, LJYoung, KH
2013
92
 
Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program
Journal:Blood
Li, YGordon, MWXu-Monette, ZYVisco, CTzankov, AZou, DQiu, LMontes-Moreno, SDybkaer, KOrazi, AZu, YBhagat, GRichards, KLHsi, EDChoi, WLvan Krieken, JHHuang, QAi, WPonzoni, MFerreri, AJWinter, JNGo, RSPiris, MAMoller, MBWu, LWang, MRamos, KSMedeiros, LJYoung, KH
2013
68
Showing results 2 to 4 of 4 < previous